Population pharmacokinetic model and limited sampling strategy for clozapine using plasma and dried blood spot samples
Background: To improve efficacy, therapeutic drug monitoring is often used in clozapine therapy. Trough level monitoring is regular, but trough levels provide limited information about the pharmacokinetics of clozapine and exposure in time. The area under the concentration time curve (AUC) is genera...
Main Authors: | Lisanne M. Geers, Dan Cohen, Laura M. Wehkamp, Hans J. van Wattum, Jos G.W. Kosterink, Anton J.M. Loonen, Daan J. Touw |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-03-01
|
Series: | Therapeutic Advances in Psychopharmacology |
Online Access: | https://doi.org/10.1177/20451253211065857 |
Similar Items
-
Pharmacokinetic Boosting of Kinase Inhibitors
by: Niels Westra, et al.
Published: (2023-04-01) -
Paralytic ileus in a patient on clozapine therapy showing an inverted clozapine/norclozapine ratio after switching valproic acid to carbamazepine: a case report
by: Geke van Weringh, et al.
Published: (2024-05-01) -
Towards the Oral Treatment of Ileo-Colonic Inflammatory Bowel Disease with Infliximab Tablets: Development and Validation of the Production Process
by: Bahez Gareb, et al.
Published: (2019-08-01) -
Population Pharmacokinetic Modelling and Limited Sampling Strategies for Therapeutic Drug Monitoring of Pyrazinamide in Patients with Tuberculosis
by: Abolhassani-Chimeh, Reihaneh, et al.
Published: (2022) -
Pharmacometabolomics may be the next stamp in the pharmacogenetic passport
by: Frank Klont, et al.
Published: (2024-06-01)